| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone deacetylase binding | 8.34e-06 | 147 | 38 | 5 | GO:0042826 | |
| GeneOntologyBiologicalProcess | cardiac muscle hypertrophy | 5.26e-06 | 142 | 37 | 5 | GO:0003300 | |
| GeneOntologyBiologicalProcess | striated muscle hypertrophy | 6.03e-06 | 146 | 37 | 5 | GO:0014897 | |
| GeneOntologyBiologicalProcess | muscle hypertrophy | 6.44e-06 | 148 | 37 | 5 | GO:0014896 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle hypertrophy | 2.69e-05 | 97 | 37 | 4 | GO:0010611 | |
| GeneOntologyBiologicalProcess | regulation of muscle hypertrophy | 3.04e-05 | 100 | 37 | 4 | GO:0014743 | |
| GeneOntologyBiologicalProcess | muscle tissue development | 5.19e-05 | 558 | 37 | 7 | GO:0060537 | |
| GeneOntologyBiologicalProcess | regulation of muscle adaptation | 9.25e-05 | 133 | 37 | 4 | GO:0043502 | |
| GeneOntologyBiologicalProcess | regulation of developmental growth | 9.49e-05 | 421 | 37 | 6 | GO:0048638 | |
| GeneOntologyBiologicalProcess | muscle structure development | 1.14e-04 | 858 | 37 | 8 | GO:0061061 | |
| GeneOntologyBiologicalProcess | muscle organ development | 1.15e-04 | 436 | 37 | 6 | GO:0007517 | |
| GeneOntologyBiologicalProcess | muscle adaptation | 2.07e-04 | 164 | 37 | 4 | GO:0043500 | |
| GeneOntologyBiologicalProcess | regulation of muscle system process | 2.42e-04 | 317 | 37 | 5 | GO:0090257 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell differentiation | 2.77e-04 | 177 | 37 | 4 | GO:0055007 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | 2.79e-04 | 327 | 37 | 5 | GO:0048738 | |
| GeneOntologyBiologicalProcess | heart development | 3.43e-04 | 757 | 37 | 7 | GO:0007507 | |
| GeneOntologyBiologicalProcess | striated muscle tissue development | 3.76e-04 | 349 | 37 | 5 | GO:0014706 | |
| GeneOntologyBiologicalProcess | embryonic heart tube morphogenesis | 3.97e-04 | 80 | 37 | 3 | GO:0003143 | |
| GeneOntologyBiologicalProcess | negative regulation of cell growth involved in cardiac muscle cell development | 4.19e-04 | 17 | 37 | 2 | GO:0061052 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle cell differentiation | 5.25e-04 | 19 | 37 | 2 | GO:0055012 | |
| GeneOntologyBiologicalProcess | cardiocyte differentiation | 6.42e-04 | 221 | 37 | 4 | GO:0035051 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle tissue growth | 7.62e-04 | 100 | 37 | 3 | GO:0055021 | |
| GeneOntologyBiologicalProcess | circulatory system development | 8.09e-04 | 1442 | 37 | 9 | GO:0072359 | |
| GeneOntologyBiologicalProcess | embryonic heart tube development | 8.31e-04 | 103 | 37 | 3 | GO:0035050 | |
| GeneOntologyBiologicalProcess | roof of mouth development | 8.54e-04 | 104 | 37 | 3 | GO:0060021 | |
| Domain | MADS_MEF2-like | 1.30e-11 | 4 | 37 | 4 | IPR033896 | |
| Domain | MADS | 1.95e-10 | 6 | 37 | 4 | SM00432 | |
| Domain | MADS_BOX_1 | 1.95e-10 | 6 | 37 | 4 | PS00350 | |
| Domain | SRF-TF | 1.95e-10 | 6 | 37 | 4 | PF00319 | |
| Domain | MADS_BOX_2 | 1.95e-10 | 6 | 37 | 4 | PS50066 | |
| Domain | TF_MADSbox | 4.54e-10 | 7 | 37 | 4 | IPR002100 | |
| Domain | HJURP_C | 2.86e-08 | 4 | 37 | 3 | IPR022102 | |
| Domain | HJURP_C | 2.86e-08 | 4 | 37 | 3 | PF12347 | |
| Domain | LIPASE_SER | 1.20e-03 | 26 | 37 | 2 | PS00120 | |
| Domain | EF-hand_1 | 3.35e-03 | 152 | 37 | 3 | PF00036 | |
| Domain | EFh | 3.74e-03 | 158 | 37 | 3 | SM00054 | |
| Domain | EF_HAND_2 | 1.06e-02 | 231 | 37 | 3 | PS50222 | |
| Domain | EF_hand_dom | 1.08e-02 | 232 | 37 | 3 | IPR002048 | |
| Pathway | WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION | 4.33e-08 | 18 | 29 | 4 | M39393 | |
| Pathway | REACTOME_MYOGENESIS | 3.31e-07 | 29 | 29 | 4 | M853 | |
| Pathway | WP_ENERGY_METABOLISM | 2.64e-06 | 48 | 29 | 4 | M39590 | |
| Pathway | WP_CELL_DIFFERENTIATION_INDEX | 3.12e-06 | 50 | 29 | 4 | M39528 | |
| Pathway | WP_CELL_DIFFERENTIATION_EXPANDED_INDEX | 6.08e-06 | 59 | 29 | 4 | M39723 | |
| Pathway | REACTOME_MYOGENESIS | 1.54e-05 | 24 | 29 | 3 | MM15174 | |
| Pathway | WP_ADIPOGENESIS | 1.41e-04 | 131 | 29 | 4 | M39505 | |
| Pathway | WP_ADIPOGENESIS_GENES | 1.68e-04 | 137 | 29 | 4 | MM15970 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | 2.60e-04 | 61 | 29 | 3 | M152 | |
| Pathway | REACTOME_ERK_MAPK_TARGETS | 9.20e-04 | 22 | 29 | 2 | M13408 | |
| Pathway | REACTOME_ABORTIVE_ELONGATION_OF_HIV_1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT | 1.01e-03 | 23 | 29 | 2 | M3630 | |
| Pubmed | 1.35e-12 | 4 | 39 | 4 | 22764880 | ||
| Pubmed | 1.35e-12 | 4 | 39 | 4 | 10207130 | ||
| Pubmed | 1.35e-12 | 4 | 39 | 4 | 8575763 | ||
| Pubmed | 1.35e-12 | 4 | 39 | 4 | 21531906 | ||
| Pubmed | Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation. | 1.35e-12 | 4 | 39 | 4 | 7643214 | |
| Pubmed | 1.35e-12 | 4 | 39 | 4 | 25416778 | ||
| Pubmed | Galpha13 regulates MEF2-dependent gene transcription in endothelial cells: role in angiogenesis. | 6.74e-12 | 5 | 39 | 4 | 19093215 | |
| Pubmed | Calcineurin initiates skeletal muscle differentiation by activating MEF2 and MyoD. | 6.74e-12 | 5 | 39 | 4 | 12694204 | |
| Pubmed | 6.74e-12 | 5 | 39 | 4 | 10458488 | ||
| Pubmed | 6.74e-12 | 5 | 39 | 4 | 8993831 | ||
| Pubmed | Regulatory role of MEF2D in serum induction of the c-jun promoter. | 6.74e-12 | 5 | 39 | 4 | 7760790 | |
| Pubmed | The MEF2B homologue differentially expressed in mouse embryonal carcinoma cells. | 6.74e-12 | 5 | 39 | 4 | 7646512 | |
| Pubmed | The expression of MEF2 genes is implicated in CNS neuronal differentiation. | 2.02e-11 | 6 | 39 | 4 | 9013788 | |
| Pubmed | MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis. | 9.42e-11 | 8 | 39 | 4 | 30205047 | |
| Pubmed | 2.82e-10 | 10 | 39 | 4 | 30276662 | ||
| Pubmed | Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. | 4.43e-10 | 11 | 39 | 4 | 9162005 | |
| Pubmed | In vivo analysis of MEF2 transcription factors in synapse regulation and neuronal survival. | 1.30e-09 | 3 | 39 | 3 | 22496871 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 26286136 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 33315889 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 27989458 | ||
| Pubmed | An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. | 1.30e-09 | 3 | 39 | 3 | 18093911 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 15834131 | ||
| Pubmed | 1.34e-09 | 14 | 39 | 4 | 12130539 | ||
| Pubmed | MEF2C transcription factor controls chondrocyte hypertrophy and bone development. | 3.18e-09 | 17 | 39 | 4 | 17336904 | |
| Pubmed | Requirement of MEF2A, C, and D for skeletal muscle regeneration. | 5.21e-09 | 4 | 39 | 3 | 24591619 | |
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 31420455 | ||
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 8817457 | ||
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 20833138 | ||
| Pubmed | Control of the SOST bone enhancer by PTH using MEF2 transcription factors. | 1.30e-08 | 5 | 39 | 3 | 17696759 | |
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 23511190 | ||
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 8900141 | ||
| Pubmed | Regulation of the MEF2 family of transcription factors by p38. | 1.30e-08 | 5 | 39 | 3 | 9858528 | |
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 15084602 | ||
| Pubmed | Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1. | 1.30e-08 | 5 | 39 | 3 | 9753748 | |
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 16504037 | ||
| Pubmed | MEF2 transcription factors are key regulators of sprouting angiogenesis. | 1.30e-08 | 5 | 39 | 3 | 27898394 | |
| Pubmed | 2.60e-08 | 6 | 39 | 3 | 20399744 | ||
| Pubmed | 2.60e-08 | 6 | 39 | 3 | 10737771 | ||
| Pubmed | Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. | 4.55e-08 | 7 | 39 | 3 | 8026334 | |
| Pubmed | 4.55e-08 | 7 | 39 | 3 | 12861002 | ||
| Pubmed | 4.74e-08 | 32 | 39 | 4 | 20111592 | ||
| Pubmed | 4.74e-08 | 32 | 39 | 4 | 21768366 | ||
| Pubmed | Mef2d is essential for the maturation and integrity of retinal photoreceptor and bipolar cells. | 4.74e-08 | 32 | 39 | 4 | 25757744 | |
| Pubmed | Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. | 7.27e-08 | 8 | 39 | 3 | 17786239 | |
| Pubmed | 7.27e-08 | 8 | 39 | 3 | 16043483 | ||
| Pubmed | 1.09e-07 | 9 | 39 | 3 | 9738004 | ||
| Pubmed | 2.85e-07 | 12 | 39 | 3 | 28641113 | ||
| Pubmed | Skeletal muscle specification by myogenin and Mef2D via the SWI/SNF ATPase Brg1. | 2.85e-07 | 12 | 39 | 3 | 16424906 | |
| Pubmed | 3.70e-07 | 13 | 39 | 3 | 21447557 | ||
| Pubmed | A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing. | 4.70e-07 | 14 | 39 | 3 | 8114702 | |
| Pubmed | Influence of natriuretic peptide receptor-1 on survival and cardiac hypertrophy during development. | 5.88e-07 | 15 | 39 | 3 | 19782130 | |
| Pubmed | 8.77e-07 | 17 | 39 | 3 | 27779093 | ||
| Pubmed | Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice. | 1.23e-06 | 2 | 39 | 2 | 16469744 | |
| Pubmed | MEF2 negatively regulates learning-induced structural plasticity and memory formation. | 1.23e-06 | 2 | 39 | 2 | 22885849 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 25336633 | ||
| Pubmed | Molecular Pathway to Protection From Age-Dependent Photoreceptor Degeneration in Mef2 Deficiency. | 1.23e-06 | 2 | 39 | 2 | 28738418 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 17431507 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 9430690 | ||
| Pubmed | MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients. | 1.23e-06 | 2 | 39 | 2 | 26921792 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 17611778 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 31722213 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 30699340 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 8798771 | ||
| Pubmed | Loss of myocyte enhancer factor 2 expression in osteoclasts leads to opposing skeletal phenotypes. | 1.23e-06 | 2 | 39 | 2 | 32512162 | |
| Pubmed | Regulation of myocyte enhancer factor-2 transcription factors by neurotoxins. | 1.23e-06 | 2 | 39 | 2 | 21741404 | |
| Pubmed | Regulation of skeletal muscle sarcomere integrity and postnatal muscle function by Mef2c. | 1.71e-06 | 21 | 39 | 3 | 17875930 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 15491989 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 1516833 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 18294453 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 15728583 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 28901289 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 15743823 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 11792813 | ||
| Pubmed | Human SRF-related proteins: DNA-binding properties and potential regulatory targets. | 3.67e-06 | 3 | 39 | 2 | 1748287 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 24043307 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 17101791 | ||
| Pubmed | Essential control of early B-cell development by Mef2 transcription factors. | 3.67e-06 | 3 | 39 | 2 | 26660426 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 15140898 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 20363751 | ||
| Pubmed | Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. | 7.34e-06 | 4 | 39 | 2 | 8548800 | |
| Pubmed | MEF2 is restricted to the male gonad and regulates expression of the orphan nuclear receptor NR4A1. | 7.34e-06 | 4 | 39 | 2 | 24694307 | |
| Pubmed | HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. | 7.34e-06 | 4 | 39 | 2 | 10523670 | |
| Pubmed | Mechanism for nucleocytoplasmic shuttling of histone deacetylase 7. | 7.34e-06 | 4 | 39 | 2 | 11585834 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 34290714 | ||
| Pubmed | Big mitogen-activated kinase regulates multiple members of the MEF2 protein family. | 7.34e-06 | 4 | 39 | 2 | 10849446 | |
| Pubmed | Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors. | 7.34e-06 | 4 | 39 | 2 | 10330143 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 36293168 | ||
| Pubmed | TEF-1 and MEF2 transcription factors interact to regulate muscle-specific promoters. | 7.34e-06 | 4 | 39 | 2 | 12061776 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 11904443 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 11809751 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 8674419 | ||
| Pubmed | Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2. | 7.34e-06 | 4 | 39 | 2 | 10531067 | |
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 12560496 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 37772772 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 25733682 | ||
| Pubmed | HDAC4 integrates PTH and sympathetic signaling in osteoblasts. | 1.22e-05 | 5 | 39 | 2 | 24934156 | |
| Pubmed | Calcium regulates transcriptional repression of myocyte enhancer factor 2 by histone deacetylase 4. | 1.83e-05 | 6 | 39 | 2 | 10825153 | |
| Pubmed | The nuclear receptor PPARβ/δ programs muscle glucose metabolism in cooperation with AMPK and MEF2. | 1.83e-05 | 6 | 39 | 2 | 22135324 | |
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 14576433 | ||
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 20590529 | ||
| Interaction | MEF2B interactions | 3.91e-09 | 11 | 39 | 4 | int:MEF2B | |
| Interaction | BORCS8-MEF2B interactions | 1.61e-08 | 15 | 39 | 4 | int:BORCS8-MEF2B | |
| Interaction | MEF2C interactions | 3.53e-06 | 54 | 39 | 4 | int:MEF2C | |
| Interaction | MEF2A interactions | 1.39e-05 | 76 | 39 | 4 | int:MEF2A | |
| Interaction | CABIN1 interactions | 1.97e-05 | 83 | 39 | 4 | int:CABIN1 | |
| Interaction | MEF2D interactions | 2.37e-05 | 87 | 39 | 4 | int:MEF2D | |
| Interaction | ASCL1 interactions | 8.99e-05 | 45 | 39 | 3 | int:ASCL1 | |
| Cytoband | 11q22.3 | 6.50e-04 | 44 | 39 | 2 | 11q22.3 | |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 3.36e-12 | 4 | 26 | 4 | 649 | |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 1.68e-11 | 5 | 26 | 4 | 1086 | |
| GeneFamily | EF-hand domain containing | 3.71e-03 | 219 | 26 | 3 | 863 | |
| Coexpression | GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_UP | 1.15e-05 | 200 | 39 | 5 | M7148 | |
| Coexpression | TURJANSKI_MAPK11_TARGETS | 2.15e-05 | 5 | 39 | 2 | M2492 | |
| Coexpression | TURJANSKI_MAPK7_TARGETS | 4.51e-05 | 7 | 39 | 2 | M11218 | |
| Coexpression | TURJANSKI_MAPK14_TARGETS | 9.63e-05 | 10 | 39 | 2 | M14718 | |
| Coexpression | GSE3982_DC_VS_NKCELL_DN | 2.07e-04 | 197 | 39 | 4 | M5480 | |
| Coexpression | GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN | 2.15e-04 | 199 | 39 | 4 | M9332 | |
| Coexpression | GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_UP | 2.15e-04 | 199 | 39 | 4 | M7650 | |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDC_DN | 2.15e-04 | 199 | 39 | 4 | M4049 | |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_STIM_MACROPHAGE_UP | 2.20e-04 | 200 | 39 | 4 | M8117 | |
| Coexpression | GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_DN | 2.20e-04 | 200 | 39 | 4 | M7744 | |
| Coexpression | GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_DN | 2.20e-04 | 200 | 39 | 4 | M5966 | |
| Coexpression | HALLMARK_MYOGENESIS | 2.20e-04 | 200 | 39 | 4 | M5909 | |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_UP | 2.20e-04 | 200 | 39 | 4 | M7294 | |
| Coexpression | GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_UP | 2.20e-04 | 200 | 39 | 4 | M8550 | |
| Coexpression | GSE42724_MEMORY_BCELL_VS_PLASMABLAST_DN | 2.20e-04 | 200 | 39 | 4 | M9791 | |
| Coexpression | GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_UP | 2.20e-04 | 200 | 39 | 4 | M8532 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_16H_BMDC_DN | 2.20e-04 | 200 | 39 | 4 | M3929 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-05 | 178 | 39 | 4 | e5e4742e35c3d90f82b830d77bdbdc45828c7deb | |
| ToppCell | droplet-Fat-Scat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 182 | 39 | 4 | fea094fe0e7796c084e60b5310c1559658633f7a | |
| ToppCell | 11.5-Airway-Mesenchymal-Pericyte|Airway / Age, Tissue, Lineage and Cell class | 2.17e-05 | 188 | 39 | 4 | 916971d8660fd20f616346953874e89d2cd13e88 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.35e-05 | 192 | 39 | 4 | 5000440dc1ed17e7474d340921bdff945646f27e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.60e-05 | 197 | 39 | 4 | 1c91e3afcc5be195b827a1dff83aff5cc2492456 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-epithelial_progenitor_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.60e-05 | 197 | 39 | 4 | c0250509836f1be04f5e54386191d7bb1e1da652 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-05 | 199 | 39 | 4 | f1723cfd6fbb8c8903a3b167872ec8523e3be250 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.76e-05 | 200 | 39 | 4 | 58a7ece7dfdf6c46f2a50cbcb580574dec14c748 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3|Control_saline / Treatment groups by lineage, cell group, cell type | 2.76e-05 | 200 | 39 | 4 | b0866b497aa71d06cef25f9a335fa584e95fa7e0 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / Treatment groups by lineage, cell group, cell type | 2.76e-05 | 200 | 39 | 4 | b1fadb2b5e37e0f51e079d8409c2647eef68dc3b | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O2-Trf|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.09e-04 | 132 | 39 | 3 | dc6edfa821a1cdc645668b0af5ba5ff80dee10bd | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.09e-04 | 132 | 39 | 3 | 60ced08bda5efc95a6f116cd0c6d1a779d99ed38 | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.33e-04 | 137 | 39 | 3 | 5e97480f014f1d9267e8126f1d0e58acd22f36aa | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-04 | 159 | 39 | 3 | 74655c22e9fdd88e3052b9dfb954c8fb678bd2d8 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Undetermined|normal_Lymph_Node / Location, Cell class and cell subclass | 3.81e-04 | 162 | 39 | 3 | 91ac35ae7fde411cd6a44e715a33dac62419cab8 | |
| ToppCell | facs-Marrow-B-cells-24m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-04 | 164 | 39 | 3 | 18eeda51e69722992c3a7f699be293535a90868b | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-04 | 165 | 39 | 3 | 22293c6b55f44636440cd737efb786ff5de3373d | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-Enterocyte_(Proximal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-04 | 165 | 39 | 3 | ce79d217df88035457cd58f679e72dd98722ae22 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Enterocyte_(Proximal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-04 | 166 | 39 | 3 | 22b31acbbef1936ce19b393cf880c63ea2fa0f1b | |
| ToppCell | facs-Marrow-B-cells-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-04 | 168 | 39 | 3 | d4053b2fffb19e0376b8ceb92e87ec4447d96a3e | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-04 | 168 | 39 | 3 | 784ce773521e5d74570f45120e56d112bc76ff49 | |
| ToppCell | facs-Marrow-B-cells-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-04 | 168 | 39 | 3 | 08fe8fa43c343c03f9a2f0b982192fde04a7c027 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.38e-04 | 170 | 39 | 3 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-04 | 170 | 39 | 3 | 75b0486620cab838d3feb1c3aa965b487a906618 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-04 | 170 | 39 | 3 | 7a4ed69c807c3761210776e8fe6680d1bd892e82 | |
| ToppCell | Pericytes-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.46e-04 | 171 | 39 | 3 | bbc8d9fc83d37c9250345b1e76776610799de9ae | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.61e-04 | 173 | 39 | 3 | 23e50492bc673aff9df95d97f0b9be4ce57cbf01 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.77e-04 | 175 | 39 | 3 | 0431897d7fcc9cefb516cd36987cf18b7f19a26a | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-04 | 176 | 39 | 3 | 7622f5a8e7320cc7b593141854107ecaf4adff7f | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 4.93e-04 | 177 | 39 | 3 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | Severe-CD4+_T_activated|World / Disease group and Cell class | 5.01e-04 | 178 | 39 | 3 | ef6111238703579a34bd6948bd9d4ca6b7e16063 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-04 | 179 | 39 | 3 | 7e6da098976c7801d31dcc0201f813d2bc8b07fc | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.18e-04 | 180 | 39 | 3 | 52e76709fa95a884ac5d910b83bd173616dac340 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-FCRL4+_Memory_B|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.18e-04 | 180 | 39 | 3 | eedb6d89680f968167afb1dcd132c9de9096b50f | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-04 | 180 | 39 | 3 | b51b10781082bc0305ba6a81e978729b329f7771 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.18e-04 | 180 | 39 | 3 | 8e96f8646c002768b272359af485dc0ab57e0ccd | |
| ToppCell | droplet-Marrow-BM|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-04 | 181 | 39 | 3 | 4169a1527b9c8f5783b8cc44e3a3924f8ed9a5e2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.26e-04 | 181 | 39 | 3 | 0bc58c8942491e7ee5b858c5742770df7677532f | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.35e-04 | 182 | 39 | 3 | 7af3b2029b7f55b923d5a4b764d4292f4ea48599 | |
| ToppCell | E18.5-samps-Endothelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.35e-04 | 182 | 39 | 3 | e2d799e6e7526176a6fe6515b8fbe4d83d3a3ea1 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-04 | 183 | 39 | 3 | 20f7b6ec2462032eda957a893ca76d5a5a01333d | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.43e-04 | 183 | 39 | 3 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.52e-04 | 184 | 39 | 3 | 2c2125b8030af83f7a6d59a7102d4de8e0ac1988 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-luminal_bladder_epithelial_cell_(umbrella_cell)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-04 | 184 | 39 | 3 | 382b1e90b3f437af596750669c0465a169d97095 | |
| ToppCell | Mild_COVID-19-Epithelial-AT1/AT2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 5.61e-04 | 185 | 39 | 3 | c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.69e-04 | 186 | 39 | 3 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.69e-04 | 186 | 39 | 3 | bca5215d406f1785bf3a420201d5686071fcaca5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.69e-04 | 186 | 39 | 3 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | facs-SCAT-Fat-3m-Lymphocytic-B_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-04 | 186 | 39 | 3 | d5d990d8b6ccd8ca8fe7d0d7dedbe2359ae7b582 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-04 | 186 | 39 | 3 | 8eafd4bea692f7ef33de27dd53f9d1fe67deaad8 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.69e-04 | 186 | 39 | 3 | cacc2f0b2ed46516173b61ba1c5c226a2db7cddc | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.69e-04 | 186 | 39 | 3 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD79a_B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-04 | 187 | 39 | 3 | b51af2824e65734f333b1325117f4a2e88b17c23 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-04 | 187 | 39 | 3 | 3ca3954f45f167e98a230f2847f0582d74fcd32e | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.87e-04 | 188 | 39 | 3 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.87e-04 | 188 | 39 | 3 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.87e-04 | 188 | 39 | 3 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.87e-04 | 188 | 39 | 3 | c2321a3a1d9603f8b4b4fc09707eb32ec1e04f3f | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.87e-04 | 188 | 39 | 3 | 1f07e3ab87173426fe0c429f5c084fb3425effd3 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.87e-04 | 188 | 39 | 3 | 85746f95319e494efdc1bbc24331698688d3a900 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.97e-04 | 189 | 39 | 3 | e82211b9dc7540e7a183be2cbcfae39fdf503949 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.97e-04 | 189 | 39 | 3 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 5.97e-04 | 189 | 39 | 3 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 6.06e-04 | 190 | 39 | 3 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.06e-04 | 190 | 39 | 3 | a7f6c38bbf451f166febb21e6719d4afced4035e | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.15e-04 | 191 | 39 | 3 | 718330bb97fe8a1ffd0c82e9af23311a32eacfe1 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.15e-04 | 191 | 39 | 3 | 454034ad940377ee079afa8ce33f8e0bdeaf44f8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.24e-04 | 192 | 39 | 3 | fee99ca7e658963acf968aa724ef8c96cfc00a5d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.24e-04 | 192 | 39 | 3 | 55f95454399fd533df75db06584eaa48d6ee3830 | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l27|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.24e-04 | 192 | 39 | 3 | 5012cc3ec0766f06af447463413422b484446c43 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam_____kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-04 | 192 | 39 | 3 | 6fb56d062c35617b18b927704bf5fba894faed81 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.24e-04 | 192 | 39 | 3 | e785135262f4c9cc66c403bf362bb34643b212c5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.24e-04 | 192 | 39 | 3 | 69758a256386a6ed3a6e2c94c55d59baa34892d7 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-04 | 193 | 39 | 3 | 54024a373e42e1c0bcc327dc084564b83b63a9d4 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-04 | 193 | 39 | 3 | 81d908594d2983ba7e7c1ec25afdde4315d9690e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.34e-04 | 193 | 39 | 3 | b52d5661edff83ac4c5fe2bf89d6672016bb827b | |
| ToppCell | 18-Airway-Mesenchymal-Pericyte|Airway / Age, Tissue, Lineage and Cell class | 6.34e-04 | 193 | 39 | 3 | 9f4ba9c29ab8071d57e4187085ec3a47ab61e968 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.34e-04 | 193 | 39 | 3 | 697518bab1338dc441b2d93b410d957e692f20e6 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-parabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-04 | 193 | 39 | 3 | 55eab7d2574e9cc2ed8f08e0a7ca7cbf90fb5818 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-epithelial_progenitor_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.43e-04 | 194 | 39 | 3 | 46e522ca59db545d1eb0c27cd4361f19d4f8f762 | |
| ToppCell | IPF-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 6.43e-04 | 194 | 39 | 3 | 3892b188f424ffb80f3c75a1b6709a21c1e1601d | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-04 | 194 | 39 | 3 | 74d0eaa76f6d9af14110dfe5b4bf9751b99ff6e3 | |
| ToppCell | Differ-Basal|World / shred by cell class for mouse tongue | 6.43e-04 | 194 | 39 | 3 | 851eff82c9f3d44c86e3e127a804bbd1fced6a7c | |
| ToppCell | PBMC-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 6.53e-04 | 195 | 39 | 3 | 674355ca00314bde90ef7f6ddb83afe2d5323130 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-04 | 195 | 39 | 3 | 8493f2f60fc356af28b9c0e287d4cd8c8899c081 | |
| ToppCell | mild-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.53e-04 | 195 | 39 | 3 | 1e5f1967bcc898318f4e970b844b4a944eb168e5 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-luminal_bladder_epithelial_cell_(umbrella_cell)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-04 | 195 | 39 | 3 | d6e2a5a15bea16de5f7ff09318c67d46ea923203 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 6.53e-04 | 195 | 39 | 3 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-aorta_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-04 | 195 | 39 | 3 | 3969b8d5fcec8ef1831531a781f7bbcebab5a4ba | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.53e-04 | 195 | 39 | 3 | b67d4f34cae729c18275486d3b20c9dd7d5cbe79 | |
| ToppCell | severe-Lymphocytic-Plasmablast|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.53e-04 | 195 | 39 | 3 | 43ff1eed563c647bc5b7b06ffe136210653c3a83 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-aortic_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-04 | 195 | 39 | 3 | 5e5ca7bd94c9e924ed76f7ccac199be745d4c4eb | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-04 | 195 | 39 | 3 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.63e-04 | 196 | 39 | 3 | 97324c9e93f833e1f218e81fb53066d44c6892df | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.63e-04 | 196 | 39 | 3 | 055993612af03bff5ef73580a6402578da850df9 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.63e-04 | 196 | 39 | 3 | 40cae477b3906623d1f2a4c630279e710499ce80 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.63e-04 | 196 | 39 | 3 | 1d94cecd378a829dd8014fc086d7fca48c953a91 | |
| ToppCell | Skin-Tubules|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 6.63e-04 | 196 | 39 | 3 | 12e21cc310a261407b46e034108e8c93ea16e045 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.63e-04 | 196 | 39 | 3 | aacec48285bcb7ccf1b538187071885e3602cc49 | |
| ToppCell | (4)_Endothelial_cells-(41)_EC-arteriolar|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.73e-04 | 197 | 39 | 3 | 482e3f8926880afed88ed37553ed2b5ed58b8c99 | |
| Drug | Metformin | 4.64e-06 | 400 | 39 | 7 | ctd:D008687 | |
| Disease | intellectual disability (implicated_via_orthology) | 2.96e-06 | 75 | 39 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 6.83e-06 | 28 | 39 | 3 | DOID:1094 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.84e-05 | 152 | 39 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | disks large homolog 3 measurement | 1.11e-04 | 12 | 39 | 2 | EFO_0802472 | |
| Disease | noggin measurement | 2.57e-04 | 18 | 39 | 2 | EFO_0021995 | |
| Disease | Psychotic Disorders | 3.25e-04 | 101 | 39 | 3 | C0033975 | |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 4.61e-04 | 24 | 39 | 2 | DOID:10595 (implicated_via_orthology) | |
| Disease | Endometrioma | 1.26e-03 | 161 | 39 | 3 | C0269102 | |
| Disease | Endometriosis | 1.26e-03 | 161 | 39 | 3 | C0014175 | |
| Disease | congestive heart failure (implicated_via_orthology) | 1.35e-03 | 41 | 39 | 2 | DOID:6000 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease | 1.42e-03 | 42 | 39 | 2 | cv:C0007959 | |
| Disease | CCL5 measurement | 3.26e-03 | 64 | 39 | 2 | EFO_0005117 | |
| Disease | Nonorganic psychosis | 3.78e-03 | 69 | 39 | 2 | C0349204 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VMFDFLDCVADLKGK | 86 | Q15173 | |
| LYTLCKEDLESMDKE | 846 | Q9Y5B0 | |
| AKYLLADCSEAFLKM | 71 | Q9H4I0 | |
| EAEKLSADCGMKYIE | 141 | Q14964 | |
| SEAMLFEEALEKYGK | 271 | O94776 | |
| FCYKAILEFAEKEGM | 566 | P43378 | |
| KKKDYCGCMIIEDED | 316 | P21397 | |
| MDKYDDLGLEASKFI | 1 | Q9UGP4 | |
| LCDSKGAYLLMELAK | 241 | Q99685 | |
| CNLLGMKIYEKDEEK | 171 | Q9HC38 | |
| KFYEGTADEMCKALL | 191 | Q16775 | |
| LDDDYNGQAKCMLEK | 136 | Q13946 | |
| VKMFEDKGLDCIFLE | 741 | Q2TBE0 | |
| FGLMKKAYELSVLCD | 26 | Q06413 | |
| FGLMKKAYELSVLCD | 26 | Q02078 | |
| EYDLLCKIMGETFKK | 936 | Q9Y4D8 | |
| KYAKICFEDNLLMGE | 86 | P58499 | |
| FGLMKKAYELSVLCD | 26 | Q02080 | |
| LKYAMFLEDEGKFEE | 1146 | Q9UG01 | |
| RGFYKMCDEDIIKLF | 886 | Q9UII4 | |
| YEDCKDLIKSMLRDE | 116 | Q9H094 | |
| LIKDLESMFKLYDAG | 91 | Q9BUP0 | |
| LTEKCKLEEDFLYMA | 3676 | Q92736 | |
| FGLMKKAYELSVLCD | 26 | Q14814 | |
| GEDDDCRYVMIFKKE | 96 | O75391 | |
| GCCLEYATMLDKEAK | 621 | Q75T13 | |
| AAGEVKALDDFYKML | 271 | Q9BRX2 | |
| MACKAYRDLAFEKGI | 216 | O95470 | |
| FLRGSLEEKMKYCFE | 96 | Q9HAE3 | |
| KEEISRYCGKEKDLM | 86 | Q9P2K2 | |
| FGDYFKELACKMALE | 106 | P49588 | |
| FDLLLDAEKCKYGME | 1471 | P24928 | |
| EKCDSYKDDLLLRMG | 6 | Q9UBT6 | |
| GYELAADKKMCEVAC | 606 | Q9Y6L7 | |
| QFGKADEMYDKCIDL | 491 | O94826 | |
| EDLSDLYQEGCGKKM | 196 | O95859 | |
| YDAFSILDMLKLEGK | 391 | Q9NYU1 | |
| LSYCLKVKEMDDEEY | 261 | Q9NRD5 | |
| YLEMEEGVKESLCAK | 611 | P22459 |